

Cover Story
COVID-19 & CancerFreeGuest Editorial
By Karen E. Knudsen and Roy A. Jensen
This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage, as well as the latest meeting cancellations, is available here.As COVID-19 has now officially been declared a source of the pandemic, with increasing incidence across the nation, it is without question that the needs of patients with particular vulnerabilities should garner particular attention.
COVID-19 & CancerFree
By Alexandria Carolan and Matthew Bin Han Ong
Clinical Roundup
Trending Stories
- Joe Fraumeni, founder of molecular epidemiology, dies at 93
“It’s hard to imagine a world without the presence of this gentle scientific giant.” - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions” - Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise
- Dana-Farber names its under-construction freestanding hospital: the Lavine Bekenstein Cancer Hospital
- To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements
















